Coordinatore | INDUSTRIAS TOBIA S.A.
Organization address
address: Calleja Vieja 62-64 contact info |
Nazionalità Coordinatore | Spain [ES] |
Totale costo | 569˙770 € |
EC contributo | 313˙000 € |
Programma | FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs |
Code Call | FP7-SME-2011 |
Funding Scheme | CP |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-09-01 - 2013-11-30 |
# | ||||
---|---|---|---|---|
1 | INDUSTRIAS TOBIA S.A. | ES | coordinator | 141˙000.00 |
2 |
TECNOLOGIAS AVANZADAS INSPIRALIA SL
Organization address
address: CALLE MIGUEL VILLANUEVA 2 6 PISO PUERTA 3 contact info |
ES (LOGRONO) | participant | 69˙136.00 |
3 |
FOS FASEROPTISCHE SYSTEME MESSTECHNIK GMBH
Organization address
address: RUTGERSSTRASSE 40 contact info |
DE (SCHACHT AUDORF) | participant | 53˙100.00 |
4 |
LINCIS SOLUCOES INTEGRADAS PARA SISTEMAS DE INFORMACAO LDA
Organization address
address: Av Senhor Da Paciencia 36 B contact info |
PT (BRAGA) | participant | 49˙764.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The Eposbed Demo project aims to bring into the market a Specialty or Medical Bed for hospitals that assist patients with limited mobility in bed. Eposbed lab-scale prototype has been successfully developed in the FP7-SME-2007-1, Eposbed project nº 222064, although we only could perform those tasks devoted to its research development. In Eposbed Demo we aim to use the advanced knowledge, complementary skills, and technological developments acquired in former Eposbed project to successfully bring the product into a commercial stage by performing a series of Demonstration activities needed for its success in the market. After having dedicated time and resources for the successful development of Eposbed lab scale prototype, we must not underestimate the importance of the necessary activities to bring it to the next level: the market. It will require a series of trials, adjustments and market activities that need to be carefully planned and coordinated. Giving the characteristics of this product as medical equipment, Manufacturers must provide clinical data of product efficacy involving a series of clinical trials that are needed before it can be placed into the market. These trials also imply that we must train and educate clinical staff on the product use and advantages. This is only one part of the complex process of bringing our innovation to the market. To fully understand the requirements of Eposbed to build the gap between our successful innovation and the market, we have performed a SWOT analysis. This analysis study the strengths, weaknesses, opportunities and threats of EposbedTM considering the achievements and successful results of Eposbed project nº 222064 while identifying the needs for this demo project activities to bring it to the market'
About one third of nurses' injuries come from moving patients. An EU-funded project designed a bed that makes this task easier.
Medical beds serve an important need for patients with limited mobility in both hospitals and homes. The project 'Demonstration action for an easy positioning for patients with reduced mobility' (http://www.eposbed.com (EPOSBED-DEMO)) has developed a medical bed for this population that makes use of technology.
The primary project objectives were to find a sensing device for a bed that is more affordable than the one currently in place, adjust the software to make it more efficient, adjust the motor of the bed, develop a lighter bed frame, and conduct clinical trials.
During the first part of the project, a lab-scale prototype was developed. Researchers then started work to prove this product is viable in the market. To accomplish this goal, they aimed to produce an industrial-scale prototype and train medical professionals.
The project accomplished many of its goals. A German manufacturer was selected to redesign aspects of the bed. A new bed frame was developed, along with a redesigned sensing device and updated software. The ethical committee cleared the project, and the bed is now ready for clinical trials at the Hospital San Pedro in Spain.
Press documents have been disseminated to spread awareness about the bed, and developers have applied for patents in the EU and the United States to extend the reach of this development.
This bed will allow users to have more mobility and autonomy over their movements. It will also take some of the physical burden of moving patients off hospital workers and caregivers. Importantly, however, this bed has the potential to improve the quality of life for patients largely confined to their beds.
An innovative phosphorus rich intumescent oligomer enabling commercially competitive high performance halogen free fire protection of polypropylene
Read MoreDevelopment of crosslinked flexible bio-based and biodegradable pipe and drippers for micro-irrigation applications
Read More